Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Life Sciences
Sudemycin E Influences Alternative Splicing And Changes Chromatin Modifications, Paolo Convertini, Manli Shen, Philip M. Potter, Gustavo Palacios, Chandraiah Lagisetti, Pierre De La Grange, Craig Horbinski, Yvonne N. Fondufe-Mittendorf, Thomas R. Webb, Stefan Stamm
Sudemycin E Influences Alternative Splicing And Changes Chromatin Modifications, Paolo Convertini, Manli Shen, Philip M. Potter, Gustavo Palacios, Chandraiah Lagisetti, Pierre De La Grange, Craig Horbinski, Yvonne N. Fondufe-Mittendorf, Thomas R. Webb, Stefan Stamm
Molecular and Cellular Biochemistry Faculty Publications
Sudemycin E is an analog of the pre-messenger RNA splicing modulator FR901464 and its derivative spliceostatin A. Sudemycin E causes the death of cancer cells through an unknown mechanism. We found that similar to spliceostatin A, sudemycin E binds to the U2 small nuclear ribonucleoprotein (snRNP) component SF3B1. Native chromatin immunoprecipitations showed that U2 snRNPs physically interact with nucleosomes. Sudemycin E induces a dissociation of the U2 snRNPs and decreases their interaction with nucleosomes. To determine the effect on gene expression, we performed genome-wide array analysis. Sudemycin E first causes a rapid change in alternative pre-messenger RNA splicing, which is …